I830127L07Rik Inhibitors
I830127L07Rik inhibitors refer to a class of chemical compounds designed to selectively target and interfere with the activity of the I830127L07Rik gene or its encoded product. I830127L07Rik is a non-coding RNA (lncRNA), a type of molecule that does not code for proteins but is recognized for its regulatory roles in controlling gene expression and various cellular processes. These inhibitors are developed with the aim of modulating the function of I830127L07Rik, which may be implicated in a range of biological processes, including gene regulation, chromatin organization, or other molecular interactions.
The primary mechanism of action for I830127L07Rik inhibitors typically involves their interaction with the I830127L07Rik RNA molecule or its associated proteins, disrupting its regulatory functions. By inhibiting I830127L07Rik, these compounds can potentially influence gene expression patterns and cellular processes that fall under its control. Researchers investigating I830127L07Rik inhibitors seek to unravel the specific roles of this lncRNA in diverse biological contexts, contributing to our understanding of its contributions to molecular and cellular biology. These inhibitors serve as valuable tools for advancing our knowledge of non-coding RNAs and their intricate roles in the regulation of genes and cellular functions. In this context, they play a significant role in advancing the field of molecular biology and gene expression research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Binds to FKBP12 and inhibits mTOR, which may downregulate protein synthesis and potentially affect I830127L07Rik expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Binds to Hsp90 and can disrupt its function, potentially affecting the stability and function of client proteins and gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
A histone deacetylase inhibitor that can cause hyperacetylation of histones, affecting chromatin structure and potentially decreasing gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor which may alter AKT signaling and could affect transcription factors and I830127L07Rik expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2 which are part of the MAPK/ERK pathway, potentially leading to altered gene expression including I830127L07Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor, potentially modifying the expression of genes regulated by this pathway, including I830127L07Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which may affect AP-1 transcription factor activity and gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor which could prevent the activation of ERK, potentially leading to downregulation of certain genes' expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that can affect multiple signaling pathways and might downregulate various genes' expression. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Known to alter the degradation of transcription factors, which can affect the expression profile of numerous genes. | ||||||